Patents by Inventor John Reno
John Reno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11922942Abstract: Devices and techniques are generally described for generating response templates for natural language processing. In various examples, a first knowledge graph comprising a plurality of entities may be received. First text data may be received for a first response template, the first text data defining a natural language input configured to invoke the first response template. A response definition may be received for the first response template, the response definition defining a response associated with the first response template. Natural language input data may be received. A determination may be made that the natural language input data corresponds to the natural language input configured to invoke the first response template. The first response template may be configured to generate natural language output data.Type: GrantFiled: June 4, 2020Date of Patent: March 5, 2024Assignee: Amazon Technologies, Inc.Inventors: Emre Can Kilinc, Thomas Reno, John Zucchi, Joshua Kaplan
-
Publication number: 20140308269Abstract: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of finding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of finding an ICAM-1 epitope are further provided.Type: ApplicationFiled: November 18, 2013Publication date: October 16, 2014Applicant: Perlan Therapeutics, Inc.Inventors: Fang FANG, Lori Kohlstaedt, John Reno
-
Patent number: 8586712Abstract: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.Type: GrantFiled: March 26, 2010Date of Patent: November 19, 2013Assignee: Perlan Therapeutics, Inc.Inventors: Fang Fang, Lori Kohlstaedt, John Reno
-
Publication number: 20110044976Abstract: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.Type: ApplicationFiled: March 26, 2010Publication date: February 24, 2011Inventors: FANG FANG, LORI KOHLSTAEDT, JOHN RENO
-
Patent number: 7696324Abstract: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.Type: GrantFiled: September 11, 2006Date of Patent: April 13, 2010Assignee: Perlan Therapeutics, Inc.Inventors: Fang Fang, Lori Kohlstaedt, John Reno
-
Patent number: 7279473Abstract: Fused pyradazine derivatives which are usefule as CDK inhibitors are described herein. The described invention alos includes methods of making such fused pyradazine derivatives as wells as methods of using the same in the treatment of hyperproliferative diseases.Type: GrantFiled: December 11, 2002Date of Patent: October 9, 2007Assignee: SmithKline Beecham CorporationInventors: Jennifer G. Badiang, Scott Howard Dickerson, Philip Anthony Harris, David Kendall Jung, Michael Robert Peel, Michael John Reno, Tara Renae Rheault, Kirk Lawrence Stevens, Francis Xavier Tavares, James Marvin Veal
-
Publication number: 20070071742Abstract: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.Type: ApplicationFiled: September 11, 2006Publication date: March 29, 2007Inventors: Fang Fang, Lori Kohlstaedt, John Reno
-
Publication number: 20060029545Abstract: Radiolabeled annexin and modified annexin conjugates useful for imaging vascular thrombi are described. Methods for making and using such radiolabeled annexin conjugates are also provided.Type: ApplicationFiled: September 27, 2005Publication date: February 9, 2006Inventors: Sudhakar Kasina, Alan Fritzberg, Jonathan Tait, John Reno
-
Publication number: 20050100545Abstract: Humanized antibodies which bind the NR-LU-13 antigen, conjugates containing such antibodies, and their use in pretargeting methods and conventional antibody therapy and immunodiagnosis are provided.Type: ApplicationFiled: July 31, 2003Publication date: May 12, 2005Applicant: NeoRx CorporationInventors: Scott Graves, John Reno, Robert Mallett, Mark Hylarides
-
Publication number: 20050036948Abstract: Radiolabeled annexin and modified annexin conjugates useful for imaging vascular thrombi are described. Methods for making and using such radiolabeled annexin conjugates are also provided.Type: ApplicationFiled: April 8, 2004Publication date: February 17, 2005Applicant: NeoRx CorporationInventors: Sudhakar Kasina, John Reno, Louis Theodore
-
Publication number: 20050008635Abstract: Humanized antibodies which bind the NR-LU-13 antigen, conjugates containing such antibodies, and their use in pretargeting methods and conventional antibody therapy and immunodiagnosis are provided.Type: ApplicationFiled: February 25, 2004Publication date: January 13, 2005Applicant: NeoRx CorporationInventors: Scott Graves, John Reno, Robert Mallett, Mark Hylarides, Stephen Searle, Andrew Henry, Jan Pedersen, Anthony Rees
-
Publication number: 20030035798Abstract: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.Type: ApplicationFiled: July 19, 2001Publication date: February 20, 2003Inventors: Fang Fang, Lori Kohlstaedt, John Reno